Notice of Funding Opportunity (NOFO) for Phase 1 Clinical Trials for HLBS Disorders
National Institutes of Health
Description
This grant opportunity is for clinical trials that can be conducted at one or multiple sites. Applicants must be prepared to start the trial within the first quarter of the project's timeline. Before receiving the award, applicants need to have regulatory approvals (FDA, DSMB, IRB), drug supplies (including placebo if needed), and any necessary third-party agreements in place. If applicants need more time and resources for pre-clinical preparation and trial readiness, they should consider ap…
The proposed trial can be single or multi-site. Applicants applying for funding under this NOFO should be ready to initiate the clinical trial within the first quarter of the project period. Discussion, submission, and attainment of applicable regulatory (FDA, DSMB, IRB) approvals, and establish…
Source
Grant ID
PAR-25-025
Agency
National Institutes of Health
Subcategory/Subagency
National Heart, Lung, and Blood Institute
Key Dates
Opportunity Released
December 5, 2024
Eligibility
The following categories of applicants are invited to apply:
- Higher Education Institutions - Public/State Controlled Institutions of Higher Education
- Higher Education Institutions - Private Institutions of Higher Education
- Nonprofits (Other than Institutions of Higher Education) with 501(c)(3) IRS Status
- Nonprofits (Other than Institutions of Higher Education) without 501(c)(3) IRS Status
- For-Profit Organizations (Other than Small Businesses)
- Small Businesses
- Local Governments
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Governments (Federally Recognized)
- Native American Tribal Governments (Other than Federally Recognized)
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
- Regional Organizations
- Federal Governments
- Eligible Agencies of the Federal Government
- U.S. Territories or Possessions
Awards & Funding
Award Ceiling
$1.5M
Funding Amount
~$1.5M
Similar opportunities
- Notice of Funding Opportunity for Phase I Clinical Trials for HLBS Disorders
National Institutes of Health
- Investigator-Initiated Early Phase Clinical Trials of Natural Products (R61/R33 Clinical Trial Required)
National Institutes of Health
- NIAMS UG3/UH3 Cooperative Agreement for Clinical Trials
National Institutes of Health
- Leveraging NICHD Clinical Research Network Infrastructure for Innovative Clinical Trials and Observational Studies
National Institutes of Health
- Investigator-Initiated Multi-Site Clinical Trials of Natural Products (UG3/UH3 Clinical Trial Required)
National Institutes of Health